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Abstract
Background: Exercise is often proposed as a non-pharmacological intervention to delay cognitive decline in
people with dementia, but evidence remains inconclusive. Previous studies suggest that combining physical
exercise with cognitive stimulation may be more successful in this respect. Exergaming is a promising
intervention in which physical exercise is combined with cognitively challenging tasks in a single session. The aim
of this study was to investigate the effect of exergame training and aerobic training on cognitive functioning in
older adults with dementia.
Methods: A three-armed randomized controlled trial (RCT) compared exergame training, aerobic training and an
active control intervention consisting of relaxation and flexibility exercises. Individuals with dementia were randomized
and individually trained three times a week during 12 weeks. Cognitive functioning was measured at baseline, after the
12-week intervention period and at 24-week follow-up by neuropsychological assessment. The domains of executive
function, episodic memory, working memory and psychomotor speed were evaluated. Test scores were converted into
standardized z-scores that were averaged per domain. Between-group differences were analysed with analysis of
covariance.
Results: Data from 115 people with dementia (mean (SD) age = 79.2 (6.9) years; mean (SD) MMSE score = 22.9
(3.4)) were analysed. There was a significant improvement in psychomotor speed in the aerobic and exergame groups
compared to the active control group (mean difference domain score (95% CI) aerobic versus control 0.370 (0.103–0.
637), p = 0.007; exergame versus control 0.326 (0.081–0.571), p = 0.009). The effect size was moderate (partial η2 = 0.102).
No significant differences between the intervention and control groups were found for executive functioning, episodic
memory and working memory.
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Conclusions: To our knowledge, this is the first RCT evaluating the effects of exergame training and aerobic training
on cognitive functioning in people with dementia. We found that both exergame training and aerobic training
improve psychomotor speed, compared to an active control group. This finding may be clinically relevant as
psychomotor speed is an important predictor for functional decline. No effects were found on executive function,
episodic memory and working memory.
Trial registration: Netherlands Trial Register, NTR5581. Registered on 7 October 2015.
Keywords: Cognition, Dementia, Alzheimer disease, Exercise, Physical activity, Cognitive stimulation, Exergame,
Neuropsychological, Randomized controlled trial
Background
The increasing prevalence of dementia greatly impacts
healthcare and society, stressing the need for global action
[1]. Since there is no cure or effective disease-modifying
drug to treat the most common types of dementia to date
[1], research should also focus on the development and
implementation of non-pharmacological interventions as
an alternative or add-on therapy [2]. Previous research has
shown that physical exercise improves cognitive perform-
ance in older adults without dementia [3], and that phys-
ical inactivity during midlife attributes to the risk of
dementia [4, 5]. However, research on cognitive effects of
physical exercise in older adults with dementia has shown
heterogeneous results [6, 7]. It seems that physical exer-
cise alone may not be enough for older adults with de-
mentia to alter or slow down cognitive decline. Previous
studies suggest that combining physical exercise with cog-
nitive stimulation may be a more successful strategy [8, 9].
Animal studies have shown that physical exercise can
prime the hippocampus to increase neurogenesis elicited
by cognitive stimuli [10, 11]. Furthermore, physical exer-
cise combined with environmental enrichment positively
affects hippocampal neurogenesis, possibly via separate
pathways, with physical exercise influencing the prolifer-
ation of neural precursor cells and environmental en-
richment fostering survival of newborn neurons [10]. In
line with this, a meta-analysis [12] showed significant
benefits of combined cognitive and physical interven-
tions on cognitive function in healthy older adults.
These beneficial effects significantly exceeded the effects
of physical exercise training alone [12]. In addition, we
recently performed a meta-analysis in older adults with
mild cognitive impairment (MCI) or dementia which
showed that combined cognitive and physical exercise
interventions improve global cognitive performance [13].
Thus, these studies illustrate the potential of combined
interventions in delaying disease progression in persons
with MCI or dementia. However, the superiority of com-
bined interventions over single physical exercise and the
effects on different cognitive domains in individuals with
dementia remain unknown. Hence, the aim of the
current study is to investigate the effects of combined
cognitive and physical exercise training on different cog-
nitive domains in people with dementia.
Recent advances in technology present the opportun-
ity to combine physical exercise with cognitively
challenging tasks in a single session using exergames
[14]. Exergaming is defined by “physical exercise inter-
actively combined with cognitive stimulation in a
virtual environment” [15]. Exergame training is a phys-
ical–cognitive dual-task training, which requires the
mental flexibility to switch between concurrent tasks. Men-
tal flexibility is a core component of executive functioning,
a set of higher-order cognitive processes also including
cognitive inhibition, planning and problem-solving [16].
We therefore hypothesize that exergame training will spe-
cifically benefit executive functioning. Previous research
has already shown that exergames improve global cognitive
function in healthy older adults and in a clinical population
of patients with Parkinson’s disease, schizophrenia, mul-
tiple sclerosis and MCI, compared to physical exercise
training alone [17]. Moreover, older adults were found to
enjoy participation in exergames, which may facilitate
long-term activity participation [18]. There is also prelim-
inary evidence that exergames are a feasible and enjoyable
intervention for people with dementia [19, 20]. To our
knowledge, no previous randomized controlled studies
have investigated the effect of exergames on cognitive
functioning, more specifically on executive functioning, in
older adults with dementia.
Previous studies suggest that the gene apolipoprotein
E (APOE) may be a moderator in the effects of exercise
on cognition [21, 22]. APOE is a cholesterol carrier and
is important for lipid transport and injury repair in the
brain [23]. There are three alleles of APOE: ε2, ε3 and
ε4. Carrying the ε4 allele of APOE is a risk factor for
Alzheimer’s disease (AD) and carrying the ε2 allele is
protective for AD [1]. Results from cohort studies are
contradictory, reporting that physical exercise is both
protective for cognitive decline in APOE ε4 carriers [24,
25] as well as lowering the risk of dementia in APOE ε4
non-carriers [26]. Insight into this moderating relation-
ship may contribute to identify people who will benefit
most from our exergame intervention.
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The primary aim of the current study is to investigate
the efficacy of a 12-week exergame training and aerobic
training compared to a control group on executive func-
tioning in older adults with dementia. We hypothesize
that exergame training results in greater improvement
on executive functioning than aerobic training. Second-
ary aims are: to assess the feasibility of exergames; to
compare effects of exergame training with single aerobic
training on the cognitive domains of psychomotor speed,
episodic memory and working memory; to measure the
follow-up effects of exergame training and aerobic train-
ing; and to determine whether the cognitive effects of
training are modified by the APOE ε4 carrier state.
Methods
Study design
The current study was a 12-week single-blind randomized
controlled trial (RCT) with two experimental intervention
groups and one active control group. Participants were in-
cluded from January 2016 to September 2017. The Med-
ical Ethics Committee of Radboud University Medical
Center in Nijmegen, the Netherlands approved the re-
search protocol, which was published previously [27]. The
study was conducted in compliance with Declaration of
Helsinki ethical standards. Participants all verbally
agreed to participate in the study and gave written in-
formed consent. The trial is registered at the Dutch
trial register (http://www.trialregister.nl) with identifi-
cation number NTR5581.
Participants and study procedures
Participants were approached via the memory clinic of
Radboudumc Alzheimer Center, day care centres for
older adults with cognitive disorders, advertisement in
local newspapers and word of mouth. Eligibility criteria
for inclusion were: clinically confirmed diagnosis of de-
mentia following the DSM-IV criteria [28] (vascular,
Alzheimer or mixed type) with a Mini Mental Status
Examination (MMSE) [29] score ≥ 17; aged 60 years or
older; if using anti-dementia medication, a stable dose
for at least 3 months before the start of the trial; and
being capable of giving informed consent [30]. Exclu-
sion criteria were: co-morbidity that limited exercising,
including severe cardiovascular, musculoskeletal or
neurological disease; diagnosis of a depression, bipolar
disorder or psychotic disorder at the moment of inclu-
sion; current drug or alcohol dependency; exercising
more than five times per week for at least 30 min at a
moderate intensity; wheelchair bound; and severe hear-
ing or visual problems that could not be corrected with
the use of hearing aids/glasses. When participants were
recruited by newspaper advertisement or word of
mouth, we confirmed the dementia diagnosis by inves-
tigating their medical record before planning a
screening visit. The study was conducted in community
centres in Nijmegen, the Netherlands. Participants were
randomly assigned to one of the intervention groups or
the control group by an independent statistician. The
minimization method [31] was used to balance groups
for gender, severity of cognitive impairment (MMSE ≥
20 or < 20), use of medication for Alzheimer’s disease,
training location and level of education. The Dutch
classification of education levels [32] was used to clas-
sify the educational attainment of participants as low
(levels 1–3), average (levels 4–5) or high (levels 6–7).
Interventions
The study included three arms: exergame training, aer-
obic training and active control. Participants in each
arm received three training sessions per week for 12
weeks. Training sessions were given on a one-on-one
basis, and trained students or research assistants super-
vised the participants. Adherence to the intervention
was calculated by dividing the number of sessions the
participant followed by the total number of sessions
that were offered.
The exergame training consisted of a combined cogni-
tive–aerobic bicycle training developed by Bike Labyrinth
(www.bikelabyrinth.com). The aerobic training compo-
nent consisted of cycling on a stationary bike, 30–50min
per session. The aerobic exercise was tailored to an indi-
vidual fitness level and health status, and aimed to achieve
an intensity of 65–75% of heart rate reserve after 12 weeks
of training [27]. For participants on medication that atten-
uates heart rate (e.g. beta-blockers), the Borg Rating of
Perceived Exertion (RPE) [33] was used to ensure that the
intended training intensity was achieved. In addition, the
stationary bike was connected to a video screen. Partici-
pants followed a route through a digital environment and
simultaneously performed cognitive tasks targeting re-
sponse inhibition, task switching and processing speed.
The exergame training consisted of seven different cog-
nitive training levels. The difficulty of the cognitive
tasks increased per level to ensure that the training
remained cognitively challenging. The exergame train-
ing and different training levels are described exten-
sively in our protocol paper [27].
The single aerobic exercise group consisted of cycling
on a stationary bike that was not connected to a video
screen. The aerobic training was identical to the exer-
game training already described. Participants in the ac-
tive control group received training that consisted of
relaxation and flexibility exercises with a duration of
30 min and the same frequency as the training regimes
of the intervention groups. The exercises required min-
imal muscle strength and aerobic capacity and were
easy to perform. The level of social engagement was
similar to the intervention groups.
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Outcomes
Full assessments were carried out before training (T0),
after the 12-week training phase (T2) and 12 weeks
thereafter at the 24-week follow-up (F1). Intermediate
measurements were performed after 6 weeks of training
(T1). Trained research assistants with a background in
neuropsychology assessed cognitive performance using
a test battery that was described previously [27], and
they were blinded to group allocation. The primary out-
come measure was objective executive functioning,
which was measured by four neuropsychological tasks
that were averaged into one domain score: a short form
of the Trail Making Test part B [34], the abbreviated
5-line Stroop Color Word Test interference score [35,
36], Letter Fluency [37, 38], and the Rule Shift Cards
Test [39]. All tests, except for letter fluency, were also
administered after 6 weeks (T1). Secondarily, the fol-
lowing cognitive domains were assessed: episodic mem-
ory (Location Learning Test—Revised [40]), working
memory (WAIS-III Digit Span [41] and WMS-III
Spatial Span [42]), and psychomotor speed (short form
of Trail Making Test part A [34] and the abbreviated
Stroop Color Word Test parts I and II [35]). Only all
psychomotor speed tests were also performed after 6
weeks (T1). Tests were categorized into cognitive do-
mains a priori using the conventional classification de-
scribed by Lezak et al. [43]. In order to calculate
domain scores, test scores were converted into z-scores
based on the mean and standard deviation of the total
sample at baseline [44]. Subsequently, these individual
test z-scores were averaged per domain.
After inclusion, saliva samples were taken with buccal
swabs for APOE genotyping. Samples were stored at −
20 °C and analysed using real-time polymerase chain re-
action (PCR) [45]. This results in different APOE gene
phenotypes: three homozygous (ε2/ε2, ε3/ε3, ε4/ε4) and
three heterozygous (ε2/ε3, ε2/ε4, ε3/ε4) [45].
Statistical analysis
Socio-demographic and clinical characteristics at
baseline were presented using descriptive statistics.
Feasibility measures (e.g. adherence to the exercise
programme, measures of exercise intensity and rating
of the exercise sessions) were compared between the
groups with one-way analysis of variance (ANOVA)
and independent-sample t test.
To assess the effect of training on cognitive perform-
ance in each domain (i.e. executive function, episodic
memory, working memory and psychomotor speed),
analysis of covariance (ANCOVA) was performed with
post-training cognitive domain z-scores as dependent
variables, baseline z-scores as covariates and group
(exergame training, aerobic training and active control)
as between-subject factors. To specify significant group
effects, Bonferroni-corrected post-hoc tests were
performed. To investigate follow-up effects of the inter-
vention for each cognitive domain, we used mixed-
model ANCOVA. Variables included in the model wer-
ecognitive domain z-scores at T2 and F1 as dependent
variables, group as between-subject factors, time as
within-subject factors, and the corresponding baseline
measure as covariates. Additionally, a time × group
interaction term was added as a fixed effect. To assess a
moderating effect of APOE ε4, an interaction term be-
tween APOE ε4 and group was added separately as a
predictor.
If a participant had missing data because he/she
was cognitively incapable to perform a certain test,
the worst possible score for this test was awarded.
Afterwards, the domain z-score was calculated. If
there were missing data due to drop-out and the rea-
son for missingness was at random, missing data were
substituted using the multiple imputation method.
Characteristic variables of the sample, cognitive do-
main scores at baseline and training group were in-
cluded in the imputation model. The following
imputation settings were used: automatic model set-
ting, 15 iterations and 5 imputations. If a participant
had missing data due to drop-out because of cognitive
decline, the criterion for missing at random was not
fulfilled. Use of multiple imputation would in this case
have been inappropriate as violation of the missing at
random assumption biases the estimates [46]. We ex-
pected that the cognitive decline would be larger in
these participants than the mean decline in the entire
group, as it was their reason for drop-out. We decided
to use a single value imputation approach for these par-
ticipants, in which we replaced the missing values by a
single value, in our case the greatest decline in the
group. To prevent imputing non-realistic values, the
lowest possible score was used as a cut-off score. We
performed additional sensitivity analyses to check
whether this alternative method of dealing with missing
data influenced our results.
All statistical analyses were performed as intention-to-
treat analyses, including all participants irrespective of
adherence to intervention. Additionally, we performed
per-protocol analyses including only those participants
who successfully completed the intervention period and
all measurements. SPSS 22 was used for all analyses with
α set at 0.05.
Results
Patient flow and sample characteristics
In total, 307 participants were screened for eligibility
and 121 participants eventually enrolled in the study.
Six participants refused to participate during baseline
measurements and the remaining 115 participants
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were randomized. Fourteen participants did not
complete the 12-week intervention (12%). The num-
ber of drop-outs did not differ significantly between
the groups (p = 0.930). The enrolment, allocation
process and reasons for drop-out are presented in
Fig. 1. Baseline characteristics for the randomized
sample were well matched between the groups
(Table 1). The included participants had a mean (SD)
age of 79.9 (6.5) years and a mean (SD) MMSE score
of 22.4 (3.2). There were no differences in age,
MMSE score and Katz index between the different
dementia types (see Additional file 1).
Attendance, intensity and safety
Table 2 presents the adherence per group; a trend was found
towards higher adherence in the exergame group compared
to the aerobic group (mean difference (95% CI) 6.85 (− 0.09
to 13.79), p= 0.053). Participants rated both exercise inter-
ventions and the active control group highly (see Table 2).
Training duration, training load, heart rate and rate of per-
ceived exertion did not differ between both intervention
groups. The mean training intensity was light in both inter-
vention groups with an average of 41.8% (SD= 13.3) and
43.5% (SD= 18.2) of maximal heart rate in the exergame
group and aerobic group respectively. For the exergame
Fig. 1 Flowchart of participants in study. ITT intention to treat, PP per protocol
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training, the median (interquartile range) training level
after 6 weeks was 5.0 (4.3–5.8), and after 12 weeks 5.5
(5.0–6.0). After 6 weeks, 25% of the participants
reached level 6 or 7, and 50% reached level 5. After 12
weeks, 50% of the participants reached level 6 or 7, and
40% reached level 5. This demonstrates that there were
no floor effects for the cognitive stimulation activity
and about half of the participants were able to complete
the highest levels, thus showing that the exergame
training was feasible and that adequate skill acquisition
was present. No occurrence of serious adverse events
(e.g. events leading to death, hospital admission or per-
sistent disability) related to the exercise interventions
were recorded.
Missing data
Missing data due to drop-out of participants was 0% at
T0, 8.7% at T1, 9.6% at T2 and 17.5% at F1. Reasons for
drop-out are described in Fig. 1. In a total of six cases,
the reason for drop-out was refused participation (five
out of six at follow-up measurements). Reason for re-
fusal was cognitive decline, which led to caregivers’ with-
drawal of consent. As explained in Methods, we used
single-value imputation for substituting missing data not
at random, and performed additional sensitivity analyses
to check whether this influenced our results. Data for
the remaining eight drop-outs were missing at random
and were substituted using multiple imputation, as ex-
plained in Methods.
Table 1 Baseline characteristics of the study population
Variable Exergame group (n = 38) Aerobic group (n = 38) Control group (n = 39)
Age (years), mean (SD) 79.0 (6.9) 80.9 (6.1) 79.8 (6.5)
Men, n (%) 20 (52.6) 21 (55.3) 21 (53.8)
Educational level, n (%)
Primary school education or lower 6 (15.8) 7 (18.4) 6 (15.4)
Secondary education or vocational training 23 (60.5) 22 (57.9) 22 (56.4)
Higher education 9 (23.7) 9 (23.7) 11 (28.2)
Mini Mental State Examination,a mean (SD) 22.9 (3.4) 22.5 (3.1) 21.9 (3.1)
Aetiology of dementia, n (%)
Alzheimer’s disease 22 (57.9) 16 (42.1) 21 (53.8)
Vascular dementia 4 (10.5) 4 (10.5) 3 (7.7)
Mixed dementia (Alzheimer/vascular) 5 (13.2) 8 (21.1) 11 (28.2)
Not specified 7 (18.4) 10 (26.3) 4 (10.3)
APOE carrier state, n (%)
ε4/ε4 1 (2.7) 5 (13.2) 3 (7.9)
ε3/ε4 20 (54.1) 13 (34.2) 16 (42.1)
ε3/ε3 15 (40.5) 16 (42.1) 16 (42.1)
ε3/ε2 0 3 (7.9) 4 (7.9)
ε2/ε4 1 (2.7) 1 (2.6) 0
ε2/ε2 0 0 0
Duration since dementia diagnosis (months), mean (SD) 13.6 (19.9) 13.8 (12.3) 18.9 (22.4)
Functional Comorbidity Index,b mean (SD) 2.5 (1.9) 2.4 (1.8) 2.2 (1.4)
Katz index,c mean (SD) 5.2 (3.3) 4.5 (3.0) 5.1 (2.9)
Number of medications used, mean (SD) 4.9 (2.9) 5.9 (3.8) 6.1 (3.7)
Use of beta-blockers, n (%) 16 (42.1) 17 (44.7) 14 (35.9)
Dementia drugs, n (%)
Rivastigmine 6 (15.8) 4 (10.5) 8 (20.5)
Donezepil 0 0 0
Galantamine 1 (2.6) 3 (7.9) 2 (5.1)
Memantine 0 1 (2.6) 0
SD standard deviation
aScores on the Mini-Mental State Examination range from 0 (severe impairment) to 30 (no impairment)
bTheoretical range 0–18, higher score indicates more co-morbidities
cTheoretical range 0–15, higher score indicates higher dependency in activities of daily living
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Intention-to-treat analysis
Figure 2 shows the performance on the four cognitive
domains at each time point per treatment arm. No sig-
nificant differences were found between the exergame
group, aerobic group and control group on executive
functioning after 12 weeks of training. Since after 6
weeks (T1) letter fluency was not administered as an
executive function test, we decided not to include T1
data in our analyses. Significant improvement on the
secondary measure psychomotor speed was found for
both the aerobic and the exergame group compared to
the controls after 12 weeks of training (mean difference
domain score (95% CI) aerobic versus control 0.370
(0.103–0.637), p = 0.007; exergame versus control 0.326
(0.081–0.571), p = 0.009). The size of the effect was
moderate (partial η2 = 0.102). This effect was not yet
present at the intermediate measurements after 6 weeks
(see Fig. 2). No significant differences were found be-
tween the groups on the secondary measures of epi-
sodic memory and working memory after the 12-week
intervention period. An additional sensitivity analysis
yielded similar results, which shows that our findings
are robust. Follow-up analysis showed that the im-
provement in psychomotor speed was maintained for
both the aerobic group and the exergame group com-
pared to the controls (mean difference domain score
(95% CI) aerobic versus control 0.453 (0.185–0.722), p
= 0.001; exergame versus control 0.326 (0.070–0.604),
p = 0.014. There was no significant difference between
the exergame and aerobic group (mean difference do-
main score (95% CI) exergame versus aerobic − 0.116
(0.399 to – 0.398), p = 0.399). We did not find any
between-group differences in any of the other cognitive
domains at follow-up. Sensitivity analysis pointed in the
same direction, with a maintenance effect in the aerobic
group compared to controls (mean difference domain
score (95% CI) aerobic versus control 0.267 (0.048–
0.486)), and no follow-up effect in any of the other cog-
nitive domains. Moderator analysis showed that carry-
ing APOE ε4 did not influence the relation between
training and cognitive performance. z-scores of the dif-
ferent cognitive domains per group and time point are
presented in Additional file 2. Raw data of cognitive
test scores are presented in Additional file 3.
Per-protocol analysis
n the per-protocol analyses, we excluded 14 participants who
did not complete the 12-week intervention period. The
remaining 101 participants were included in this analysis.
The results of the per-protocol analyses were in line with the
intention-to-treat analyses, with positive effects of exergame
and aerobic training on psychomotor speed compared to
controls (mean difference domain score (95% CI) aerobic
versus control 0.322 (0.038–0.607), p = 0.021; exergame ver-
sus control 0.283 (0.002–0.563), p = 0.047). As in the
intention-to-treat analyses, no significant between-group dif-
ferences were observed in the domains of executive function,
memory and working memory. At follow-up there were nine
additional drop-outs, which led to inclusion of 92 partici-
pants in the follow-up analysis. We found that there was a
trend for maintained improvement in psychomotor speed
at 24-week follow-up in the aerobic group compared to
Table 2 Training characteristics of the study population
Variable Exergame group (n = 38) Aerobic group (n = 38) Control group (n = 39)
Adherence rate (%), mean (SD) 87.3 (13.6)* 81.1 (13.7)* 85.4 (12.9)
Duration training session (min), mean (SD) 32.6 (6.0) 30.5 (8.7) 30a
Training load (W), mean (SD) 53.7 (34.9) 51.2 (27.7) NA
Resting heart rate (beats/min), mean (SD) 79.4 (12.1) 77.9 (10.4) NA
Heart rate during training (beats/min), mean (SD) 105.5 (14.8) 103.9 (14.3) NA
Heart rate difference (beats/min), mean (SD) 26.1 (15.1) 26.0 (13.8) NA
Training intensityb (% of maximal heart rate), mean (SD) 41.8 (13.3) 43.5 (18.2) NA
Rate of perceived exertion during training,c mean (SD) 13.1 (1.2) 12.8 (1.9) NA
Rating of training sessionsd (scale 1–5), Median (interquartile range) 5.0 (4.0–5.0) 5.0 (4.0–5.0) 5.0 (4.0–5.0)
Training level after 6 weeksd (scale 1–7), Median (interquartile range) 5.0 (4.3–5.8) NA NA
Training level after 12 weeksd (scale 1–7), Median (interquartile range) 5.5 (5.0–6.0) NA NA
Differences between groups tested with one-way analysis of variance (three groups) or independent-sample t test (two groups), if data were normally distributed.
For post-hoc comparisons, Tukey honest significant difference test was performed. If data was not normally distributed, Kruskall Wallis test was performed.
NA not applicable, SD standard deviation
aAll training sessions lasted for 30min, time has not been recorded
bTraining intensity only calculated for participants who do not use beta-blockers (n = 21 and n = 20 in the exergame group and the aerobic group respectively)
cTheoretical range 6–20, where 6 indicates lowest intensity level and score 20 indicates highest intensity level
dData not normally distributed, therefore presented as median (interquartile range)
*A trend was found towards higher adherence in the exergame group compared to the aerobic group (mean difference (95% confidence interval) 6.85 (− 0.09 to
13.79), p = 0.053)
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the control group (mean difference domain score (95%
CI) aerobic versus control 0.267 (0.048–0.486), p = 0.057).
No significant intervention effects were observed in any
of the other domains.
Discussion
To our knowledge, this is the first randomized con-
trolled trial to investigate the differential effect of exer-
gaming versus aerobic training on cognitive functioning
in people with dementia. We hypothesized that exer-
game training would result in greater improvement on
executive functioning than single aerobic training. Al-
though we did not find an effect of exergame training
or aerobic exercise on executive function after 12
weeks, we found that psychomotor speed improved in
both the exergame and the aerobic group compared to
active controls. This effect was maintained at the
24-week follow-up. We did not find an effect of both
intervention groups in the cognitive domains of epi-
sodic memory and working memory compared to the
control group. Moderator analysis showed that APOE
ε4 carriership did not influence the relation between
training and cognitive function. Finally, we demon-
strated that a newly developed exergame that comprises
both physical and cognitive training elements is feasible
for people with dementia.
Interpretation of results and comparison with previous
research
Contrary to our hypothesis, the current results did not
show a larger effect of exergame training compared to
aerobic training on cognitive functioning. Comparable
research on the differential effects of combined cogni-
tive and physical training versus only cognitive or phys-
ical interventions in people with dementia is scarce.
There is one previously published paper reporting that
neither a 12-week combined cognitive–aerobic training
nor aerobic training only improved global cognitive
function in a smaller sample of 80 individuals with AD
[47]. However, the type of intervention and used out-
come measures are incomparable to the current study.
Research in individuals with MCI showed inconsistent
Fig. 2 Mean z-scores and standard errors of mean (SEM) at baseline, after 12 weeks and after 24 weeks for domains of executive function,
psychomotor speed, episodic memory and working memory. Arrows represent SEM. *Significant effect (p < 0.05) of exergame training and
aerobic training on psychomotor speed compared to controls after 12 weeks; §maintenance effect (p < 0.05) of aerobic and exergame training on
psychomotor speed at 24-week follow-up
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findings regarding the cognitive benefits of combined
interventions and its potential superiority compared to
physical exercise or cognitive training alone [48]. In
contrast, for older adults without cognitive impairment
there is converging evidence that combined interven-
tions (including exergames) are superior to physical or
cognitive training alone [48], with larger effect sizes for
interventions that are performed simultaneously com-
pared to sequential interventions [12].
In healthy older adults, evidence for the efficacy of
physical exercise and combined cognitive and physical
interventions on executive functions [12, 49], memory
[12, 49], working memory [12, 50] and attention [51]
have been well established. In our current study, both
exergame and aerobic-only training did not positively
affect executive functions, working memory or episodic
memory. This seems partly in line with previous re-
search. A meta-analysis performed by our group [13]
demonstrated positive effects of combined interventions
on global cognitive function in older adults with MCI or
dementia, but no effects in the domains of executive
function and memory. In contrast, a recently published
RCT showed that both a mentally challenging exergame
and a passive exergame improve executive functioning
in people with MCI [52]. However, the more challenging
exergame only yielded significant effects after 6 months
of training, while the passive exergame already produced
gains after 3 months [52]. A possible explanation for this
discrepancy is that participants in the mentally challen-
ging exergame group needed more time to master the
intervention, which may have delayed triggering the syn-
ergistic effects of the combined intervention [52]. This
might also explain the negative findings in our study,
since a mentally challenging exergame was used for a
relative short intervention period of 12 weeks.
There is evidence that the severity of neurocognitive
disorder has a moderating impact on the cognitive ef-
fects of combined cognitive and physical training [53].
An increase in the severity of neurocognitive disorder
may lead to a decrease of the intervention effect [53].
This could be explained by a reduced structural brain
capacity (e.g. reduced number of neurons and synapses)
in participants with more severe neurocognitive disorder,
which may lead to limited resources necessary for
training-induced gains [53]. Therefore, it may be more
difficult to induce cognitive benefits in people with de-
mentia compared to those with MCI or healthy older
adults. Moreover, the complexity to obtain valid neuro-
psychological outcomes that are sensitive to change in
persons who already have severe cognitive deficits due
to their dementia complicates the assessment of cogni-
tive functioning in this group. Even though we carefully
selected and adjusted tests for use in mild-to-moderate
dementia, it is particularly challenging to assess executive
functions in this group. Executive functions include
higher-order processes such as inhibitory control, men-
tal flexibility and planning, which are already affected
in the early stages of dementia [54, 55]. Assessment of
executive function in people with dementia may conse-
quently result in floor effects or missing data, which
make it difficult to measure change over time.
In our study we found a moderate effect of exergame
training and aerobic training on psychomotor speed
after a 12-week training period in people with demen-
tia. This effect was not yet present after 6 weeks of
training. Firstly, this may imply that the improvement
is due to the training and not due to non-specific treat-
ment or practice effects. Secondly, this suggests that a
longer training duration is necessary to improve psy-
chomotor speed. Although still under debate, there is
some evidence that physical exercise leads to improved
cognitive function through promotion of hippocampal
neurogenesis [56], brain angiogenesis [57] and synaptic
plasticity [58] elicited by an increased expression of
neurotrophic factors [59]. In cognitively healthy older
adults, physical exercise interventions have the largest
gains on executive control processes, psychomotor
speed and attention [49, 51, 60, 61]. In people with de-
mentia there is little research about the benefits for dif-
ferent cognitive domains. From a neurobiological
perspective, however, we do not have an explanation
for why exercise would only improve psychomotor
speed, but not the other cognitive skills assessed. We
hypothesize, that only finding an effect on psychomotor
speed, and not on executive functioning, may be related
to domain-specific responsiveness of the selected out-
come measures. Processing speed tests typically are
continuous outcome measures without ceiling or floor
effects that are highly sensitive [62], which may explain
the sensitivity to change even in a dementia sample. In
contrast, tests that measured executive functioning re-
sulted in floor effects in our dementia sample, which
made it difficult to measure change over time. Alterna-
tively, one could also hypothesize that mood may be a
mediating factor for improvement on speed measures,
as previous research showed that exercise and exer-
game training can reduce depressive symptoms in
healthy older adults [63, 64]. The positive effect on psy-
chomotor speed was consistent across the different
neuropsychological tests used to measure psychomotor
speed (short form of Trail Making Test part A and the
abbreviated Stroop Color Word Test parts I and II),
which shows that the effect was robust and reliable. Its
moderate effect size is slightly larger than to the
small-to-moderate effect sizes commonly found in
studies examining the effects of cholinesterase inhibi-
tors on cognitive function [65, 66]. Given that interven-
tions to ameliorate cognitive decline of people with
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dementia are scarce, this effect size may be clinically
relevant. Poor processing speed is a predictor of func-
tional decline in basic and instrumental activities of
daily living [67]. In addition, poor processing speed is
reported to be a predictor for incident dementia [68]
and was found to be associated with shorter survival
among older adults in Japan [69]. Furthermore, late-life
cognitive decline is attributable to slower processing speed
[70]. Thus, the reported improvement in processing speed
may be clinically relevant.
The mean training intensity was light in both inter-
vention groups, with an average of 41.8% (SD = 13.3)
and 43.5% (SD = 18.2) of maximal heart rate in the
exergame group and the aerobic group respectively. We
expected that improved cardiorespiratory fitness would
be a requirement to improve cognitive function [51],
and therefore we aimed to achieve moderate exercise
intensity (e.g. 65–75% of maximal heart rate) during
the training sessions. However, the exercise training
was tailored to an individual fitness level and health
status, and most participants were not able to achieve a
moderate training intensity. The recently published De-
mentia and Physical Activity (DAPA) trial [71] showed
that moderate to high-intensity aerobic and strength
exercise training did not slow cognitive decline in
people with mild to moderate dementia, and even
worsened cognitive impairment in those who complied
with the intervention, despite an improvement in phys-
ical fitness. It is therefore unlikely that the light training
intensity in our study limited the beneficial effects of
exercise on cognitive functioning.
Strengths and limitations
The strengths of our study include the inclusion of a
relatively large sample of people with dementia, a high
adherence rate, the use of a comprehensive neuro-
psychological assessment and follow-up measurement
for long-term maintenance effects. However, some limi-
tations need to be taken into account when interpreting
our results. Firstly, only participants who were mobile
and motivated enrolled in our study, which may limit
the external validity of the current findings. Secondly,
participants were not blinded to allocation, which is an
unavoidable limitation of exercise studies. Outcome
assessors were masked for intervention allocation.
Thirdly, although we used adapted versions of executive
tests, making administration in people with dementia
more feasible, a floor performance was still found in a
number of individuals. This may have reduced the sen-
sitivity to measure change over time, obscuring poten-
tial positive results. Fourthly, the intervention period
was only 12 weeks, which may have been too short to
show beneficial effects of exergames on executive func-
tioning. Lastly, future studies should include measures
of mood, since this might be a potential mediating fac-
tor for the improvement in processing speed measures.
Clinical relevance and feasibility
Both exergame training and aerobic training improved
psychomotor speed after 12 weeks, with a moderate ef-
fect size. This finding may be clinically relevant as psy-
chomotor speed is an important predictor for
functional decline. In our study, exergame training was
not superior to aerobic training. However, there was a
trend for higher adherence in the exergame group
compared to the aerobic group. Additionally, trainers
who individually guided the training sessions reported
that it was easier to motivate participants in the exer-
game group and to increase duration of the training
sessions. This was confirmed by our finding that no
participants dropped out in the exergame group due to
low motivation (see Fig. 1). Accordingly, exergaming
seems to be an effective method to stimulate
long-term physical activity participation in people with
dementia.
Future directions
Future studies should examine whether certain individ-
ual characteristics (e.g. type of dementia) moderate the
effect of physical activity on cognition. Insight into
these individual differences is important because it can
determine which people are most likely to benefit from
physical activity. It can also help to personalize inter-
ventions, thereby stimulating physical activity. More-
over, additional studies are needed to explore the
optimal intervention design and dose–response for eli-
citing beneficial cognitive effects in people with demen-
tia. Future intervention trials should include measures
of psychomotor speed as these can reliably and validly
be assessed in people with dementia and are closely re-
lated to everyday activities. Furthermore, studies should
also focus on investigating neurophysiological mecha-
nisms that underlie the cognitive effects of exercise, for
example by including neuroimaging measures.
Conclusions
Exergaming is a feasible and highly appreciated exercise
method to engage older adults with dementia in phys-
ical exercise, mixed with cognitive stimulation. Both
exergame training and aerobic training can improve
psychomotor speed, which may be clinically relevant as
psychomotor speed is an important predictor for func-
tional decline. Although no effects were found on
executive function, episodic memory and working
memory, the potential broad range of effects of exer-
games for older adults with dementia (e.g. physical
functioning, quality of life, activities in daily living)
should be studied in future RCTs.
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